相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Wnt signalling and breast tumour growth by the multi-purpose drug suramin through suppression of heterotrimeric G proteins and Wnt endocytosis
Alexey Koval et al.
BIOCHEMICAL JOURNAL (2016)
Metformin suppresses hypoxia-induced stabilization of HIF-1′ through reprogramming of oxygen metabolism in hepatocellular carcinoma
Xinke Zhou et al.
ONCOTARGET (2016)
Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs
Xiaoli Huang et al.
BMC CANCER (2016)
Hedgehog Pathway Inhibition
Aleksandar Sekulic et al.
CELL (2016)
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
Kei Satoh et al.
CLINICAL CANCER RESEARCH (2016)
Repurposing metformin for cancer treatment: current clinical studies
Young Kwang Chae et al.
ONCOTARGET (2016)
Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling
Hui Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure
Robert A. Mook et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression
HuaPing Li et al.
CANCER CELL INTERNATIONAL (2015)
Aspirin and NSAIDs for breast cancer chemoprevention
Eugenia Ch Yiannakopoulou
EUROPEAN JOURNAL OF CANCER PREVENTION (2015)
Frizzleds and WNT/β-catenin signaling - The black box of ligand-receptor selectivity, complex stoichiometry and activation kinetics
Gunnar Schulte
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1-5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways
Gangappa Dharmapuri et al.
LEUKEMIA RESEARCH (2015)
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Shingo Eikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation
Yue Zhou et al.
ONCOTARGET (2015)
Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies
Yan-Peng Zhang et al.
Scientific Reports (2015)
Molecular Pathways: Aspirin andWnt Signaling-A Molecularly Targeted Approach to Cancer Prevention and Treatment
Manish K. Gala et al.
CLINICAL CANCER RESEARCH (2015)
Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study
Adriana C. Vidal et al.
CLINICAL CANCER RESEARCH (2015)
The Evolving Role of Nonsteroidal Anti-Inflammatory Drugs in Colon Cancer Prevention: A Cause for Optimism
Basil Rigas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo
Danxin Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling
A. V. Koval et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Molecular targets of aspirin and cancer prevention
L. Alfonso et al.
BRITISH JOURNAL OF CANCER (2014)
Republished research: Non-steroidal anti-inflammatory drugs (NSAIDs) (vol 47, pg 1127, 2013)
R. O. Day et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2014)
Wnt signaling in adult intestinal stem cells and cancer
Michaela Krausova et al.
CELLULAR SIGNALLING (2014)
Delivery of Suramin as an Antiviral Agent through Liposomal Systems
Eloise Mastrangelo et al.
CHEMMEDCHEM (2014)
NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
Alice Melotti et al.
EMBO MOLECULAR MEDICINE (2014)
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2014)
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Joong Sup Shim et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
The impact of pyrvinium pamoate on colon cancer cell viability
Armin Wiegering et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Salinomycin Suppresses LRP6 Expression and Inhibits Both Wnt/β-catenin and mTORC1 Signaling in Breast and Prostate Cancer Cells
Wenyan Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Effect of Niclosamide on Basal-like Breast Cancers
Angelina I. Londono-Joshi et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
Tinghong Ye et al.
PLOS ONE (2014)
An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control
Hans Clevers et al.
SCIENCE (2014)
Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway
Shuai Zhang et al.
TOXICOLOGY LETTERS (2014)
Roles of Wnt/beta-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment
J. Mao et al.
CELL DEATH & DISEASE (2014)
Diabetes, pancreatic cancer, and metformin therapy
Jun Gong et al.
FRONTIERS IN PHYSIOLOGY (2014)
Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation
Andrea Venerando et al.
BIOCHEMICAL JOURNAL (2013)
Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
Guofang Hou et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Celecoxib Downregulates CD133 Expression Through Inhibition of the Wnt Signaling Pathway in Colon Cancer Cells
Yanhong Deng et al.
CANCER INVESTIGATION (2013)
Anticancer Effects of Niclosamide in Human Glioblastoma
Anja Wieland et al.
CLINICAL CANCER RESEARCH (2013)
The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells
Soshi Kusunoki et al.
GYNECOLOGIC ONCOLOGY (2013)
Wnt Secretion and Gradient Formation
Gonzalo P. Solis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling
Nan Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
Rui Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Nonsteroidal Anti-inflammatory Drugs Diclofenac and Celecoxib Attenuates Wnt/β-Catenin/Tcf Signaling Pathway in Human Glioblastoma Cells
Gangadhara Reddy Sareddy et al.
NEUROCHEMICAL RESEARCH (2013)
Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines
Lei He et al.
PANCREATOLOGY (2013)
AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling Activity
H. T. Kwan et al.
PLOS ONE (2013)
A Wnt-er Migration: The Confusing Role of β-Catenin in Melanoma Metastasis
Marie R. Webster et al.
SCIENCE SIGNALING (2013)
Challenges and opportunities of drug repositioning.
Natalia Novac
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Niclosamide suppresses hepatoma cell proliferation via the Wnt pathway
Minoru Tomizawa et al.
ONCOTARGETS AND THERAPY (2013)
Pyrvinium targets autophagy addiction to promote cancer cell death
Longfei Deng et al.
CELL DEATH & DISEASE (2013)
A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis
Peter Babokhov et al.
PATHOGENS AND GLOBAL HEALTH (2013)
Clinical evidence for the use of aspirin in the treatment of cancer
Ruth E. Langley
ECANCERMEDICALSCIENCE (2013)
Antiproliferative activity of salinomycin and its derivatives
Adam Huczynski et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine
G. Xie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes
Maryam B. Lustberg et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3
Yasuo Harada et al.
CANCER LETTERS (2012)
Platforms for high-throughput screening of Wnt/Frizzled antagonists
Alexey Koval et al.
DRUG DISCOVERY TODAY (2012)
Drugging Wnt signalling in cancer
Paul Polakis
EMBO JOURNAL (2012)
Metformin targets ovarian cancer stem cells in vitro and in vivo
Jessica J. Shank et al.
GYNECOLOGIC ONCOLOGY (2012)
An anticancer agent, pyrvinium pamoate inhibits the NADH-fumarate reductase system-a unique mitochondrial energy metabolism in tumour microenvironments
Eriko Tomitsuka et al.
JOURNAL OF BIOCHEMISTRY (2012)
Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling
Bruno D. Fonseca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
Cord Naujokat et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
Kiyohito Kato et al.
MOLECULAR CANCER THERAPEUTICS (2012)
In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma
Young Kim et al.
LEUKEMIA RESEARCH (2012)
Wnt Signaling and Injury Repair
Jemima L. Whyte et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
Jing-Xuan Pan et al.
CHINESE JOURNAL OF CANCER (2012)
Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
Timothy Lynagh et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Nonsteroidal Antiinflammatory Drugs and Bladder Cancer: A Pooled Analysis
Sarah E. Daugherty et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteins
Alexey Koval et al.
BIOCHEMICAL JOURNAL (2011)
Yellow submarine of the Wnt/Frizzled signaling: Submerging from the G protein harbor to the targets
Alexey Koval et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells
Seyeon Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2011)
Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)
Valerie A. McCormack et al.
CANCER CAUSES & CONTROL (2011)
Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
Qing-Lian Tang et al.
CANCER LETTERS (2011)
Inhibition of PDE5 by Sulindac Sulfide Selectively Induces Apoptosis and Attenuates Oncogenic Wnt/β-Catenin-Mediated Transcription in Human Breast Tumor Cells
Heather N. Tinsley et al.
CANCER PREVENTION RESEARCH (2011)
Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
Takuya Osada et al.
CANCER RESEARCH (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
FZD7 has a critical role in cell proliferation in triple negative breast cancer
L. Yang et al.
ONCOGENE (2011)
Sulindac Sulfide Reverses Aberrant Self-Renewal of Progenitor Cells Induced by the AML-Associated Fusion Proteins PML/RARα and PLZF/RARα
Gunnar Steinert et al.
PLOS ONE (2011)
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
Wenyan Lu et al.
PLOS ONE (2011)
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
Desheng Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intervening in β-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis
Ulrike Stein et al.
NEOPLASIA (2011)
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
Sumaiya Sharmeen et al.
BLOOD (2010)
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer
Elaine T. Lam et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
Yanli Jin et al.
CANCER RESEARCH (2010)
Dishevelled: The hub of Wnt signaling
Chan Gao et al.
CELLULAR SIGNALLING (2010)
Chemical-Genetic Screen Identifies Riluzole as an Enhancer of Wnt/β-catenin Signaling in Melanoma
Travis L. Biechele et al.
CHEMISTRY & BIOLOGY (2010)
Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Fumi Takahashi-Yanaga et al.
CLINICAL CANCER RESEARCH (2010)
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Farhat V. N. Din et al.
GUT (2010)
Celecoxib Inhibits β-Catenin-dependent Survival of the Human Osteosarcoma MG-63 Cell Line
J-J Xia et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Curtis A. Thorne et al.
NATURE CHEMICAL BIOLOGY (2010)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Steven M. Paul et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A Direct and Functional Interaction Between Go and Rab5 During G Protein-Coupled Receptor Signaling
Vladimir Purvanov et al.
SCIENCE SIGNALING (2010)
Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
Joshua C. Curtin et al.
ONCOTARGET (2010)
Wnt signal transduction pathways
Yuko Komiya et al.
Organogenesis (2010)
Sulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein Dishevelled
Ho-Jin Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
Minyong Chen et al.
BIOCHEMISTRY (2009)
Amide derivatives of ethacrynic acid: Synthesis and evaluation as antagonists of Wnt/β-catenin signaling and CLL cell survival
Guangyi Jin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Hexachlorophene suppresses β-catenin expression by up-regulation of Siah-1 in EBV-infected B lymphoma cells
Hye-Jin Min et al.
CANCER LETTERS (2009)
A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity
Gary A. Piazza et al.
CANCER PREVENTION RESEARCH (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Wnt-Related Molecules and Signaling Pathway Equilibrium in Hematopoiesis
Sachin Malhotra et al.
CELL STEM CELL (2009)
A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma
Dana Yip et al.
CLINICAL CANCER RESEARCH (2009)
The trimeric G protein Go inflicts a double impact on axin in the Wnt/frizzled signaling pathway
Diane Egger-Adam et al.
DEVELOPMENTAL DYNAMICS (2009)
Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
Wenyan Lu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Autonomous Notch Signal Pathway Is Activated by Baicalin and Baicalein But Is Suppressed by Niclosamide in K562 Cells
An-Ming Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Aspirin, salicylates, and cancer
Peter C. Elwood et al.
LANCET (2009)
Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway
Desheng Lu et al.
PLOS ONE (2009)
Non-competitive androgen receptor inhibition in vitro and in vivo
Jeremy O. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
Andy J. Chien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin
Jurien S. Lagas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Celecoxib-induced degradation of T-cell factors-1 and-4 in human colon cancer cells
Fumi Takahashi-Yanaga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and wnt activity in colon cancer
Jurriaan B. Tuynman et al.
CANCER RESEARCH (2008)
Sulindac suppresses β-catenin expression in human cancer cells
Anjia Han et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Trimeric G protein-dependent signaling by Frizzled receptors in animal development
Diane Egger-Adam et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
Won Park et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy
De-Hua Yu et al.
PLOS ONE (2008)
Novel agents for cancer prevention based on nitric oxide
B. Rigas
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Aspirin activates the NF-κB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer
Lesley A. Stark et al.
CARCINOGENESIS (2007)
Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells
Naoko Sakoguchi-Okada et al.
BIOCHEMICAL PHARMACOLOGY (2007)
R-Etodolac decreases β-catenin levels along with survival and proliferation of hepatoma cells
Jaideep Behari et al.
JOURNAL OF HEPATOLOGY (2007)
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence
Eric J. Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Comparative evaluation of acute toxicity of ivermectin by two methods after single subcutaneous administration in rats
S. S. Dadarkar et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
The use of aspirin for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Catherine Dube et al.
ANNALS OF INTERNAL MEDICINE (2007)
β-Catenin destruction complex:: insights and questions from a structural perspective
D. Kimelman et al.
ONCOGENE (2006)
Mining the Wnt pathway for cancer therapeutics
Nick Barker et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Effect of aspirin on the Wnt/β-catenin pathway is mediated via protein phosphatase 2A
C. L. Bos et al.
ONCOGENE (2006)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hexachlorophene inhibits Wnt/β-catenin pathway by promoting Siah-mediated β-catenin degradation
Seoyoung Park et al.
MOLECULAR PHARMACOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Effect of indomethacin on E-cadherin and β-catenin expression in HT-29 colon cancer
S Kapitanovic et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
被撤回的出版物: Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer (Retracted Article. See vol 91, pg 2118, 2006)
AS Rao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Wnt signaling: is the party in the nucleus?
Karl Willert et al.
GENES & DEVELOPMENT (2006)
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis
MD Castellone et al.
SCIENCE (2005)
Ivermectin 20 years on: maturation of a wonder drug
TG Geary
TRENDS IN PARASITOLOGY (2005)
Prostaglandin E2 stimulates the β-catenin/T cell factor-dependent transcription in colon cancer
JY Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
JJ Ord et al.
BRITISH JOURNAL OF CANCER (2005)
Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases
DF McCain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines
EMJ Boon et al.
BRITISH JOURNAL OF CANCER (2004)
Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid
DE Nix et al.
TUBERCULOSIS (2004)
Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders
A Pardanani et al.
BLOOD (2004)
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma
P Merle et al.
GASTROENTEROLOGY (2004)
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer
C Wissmann et al.
JOURNAL OF PATHOLOGY (2003)
Caught up in a Wnt storm: Wnt signaling in cancer
RH Giles et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2003)
A role of dishevelled in relocating axin to the plasma membrane during wingless signaling
A Cliffe et al.
CURRENT BIOLOGY (2003)
Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity
L Zhou et al.
CANCER LETTERS (2003)
Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
DA Corley et al.
GASTROENTEROLOGY (2003)
Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects
CA Guzzo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Suramin's development: What did we learn?
M Kaur et al.
INVESTIGATIONAL NEW DRUGS (2002)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells
G Hawcroft et al.
CARCINOGENESIS (2002)
Inhibition of β-catenin translocation in rodent colorectal tumors -: A novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancer
WA Brown et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Suppression of occurrence and advancement of β-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib
Y Yamada et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Breast cancer and NSAID use: a meta-analysis
SA Khuder et al.
BRITISH JOURNAL OF CANCER (2001)
Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation
WA Brown et al.
GUT (2001)
The ABC of APC
NS Fearnhead et al.
HUMAN MOLECULAR GENETICS (2001)
Genotoxicity of streptonigrin:: a review
AD Bolzán et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2001)
The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling
S Dihlmann et al.
ONCOGENE (2001)
A positive role for the PP2A catalytic subunit in Wnt signal transduction
MJ Ratcliffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action
ML Smith et al.
EUROPEAN JOURNAL OF CANCER (2000)
A pilot trial of suramin in metastatic breast cancer to assess antiangiogenic activity in individual patients
WJ Gradishar et al.
ONCOLOGY (2000)
分享论文
